H. Rieder (Kirchlindach, Switzerland), P. Kelly (Dublin, Ireland)
Treatment results of new tuberculosis cases from Istanbul dispanseries in 1998
Z. Kilicaslan, C. Kücük, N. Sarimurat, F. Ozturk, N. Aydemir, A. Erem (Istanbul, Turkey)
|  |
Is it possible to achieve treatment success, recommended by WHO in country with high level of multidrug resistant TB?
V. Riekstina, V. Leimane, J. Leimans (Riga, Latvia)
| |
Treatment of multidrug resistant tuberculosis in penitentiary system of Tomsk Oblast
K. V. Goncharova, A. D. Pasechnikov, O. S. Kostornoy, A. V. Barnashov, S. P. Mishustin, E. G. Andreev, A. M. Sloutsky, A. A. Trusov, O. I. Ponomorenko (New York, Boston, United States Of America; Tomsk, Russia)
| |
Efficiency of standard chemotherapy of patients with pulmonary TB with relapses and treatment failure at drug resistance of M. tuberculosis
S. S. Ismailov, M. M. Adenov, G. A. Musabekova (Almaty, Kazakhstan)
| |
The efficiency of treatment of new cases of pulmonary TB in the hospital setting
A. A. Toktogonova (Bishkek, Kyrgyzstan)
| |
Treatment of ulcerative endobronchial tuberculosis and bronchial stenosis with aerosolized streptomycin and steroids
E. Sugihara, Y. Kido, N. Hirota, T. Rikimaru, K. Oizumi (Kurume, Japan)
| |
Treatment results of cases of severe pulmonary tuberculosis with using rifabutin
S. A. Cherenko, V. M. Petrenko, I. V. Sluch, L. M. Tsygankova (Kyiv, Ukraine)
| |
Time course of sputum positivity during chemotherapy in smear-positive pumonary tuberculosis
V. A. M. Martino, R. M. Refini, G. Ciarleglio, L. Scarsella, R. Amerini, P. Sestini (Siena, Italy)
| |
Results of the treatment of relapses of tuberculosis by DOTS method
M. D. Safaryan, G. R. Minassian (Yerevan, Armenia)
| |
Myrin P implementation in the chemotherapy standard regimens
G. C. Smailova (Almaty, Kazakhstan)
| |
Evaluation of empirical treatment of tuberculosis (TB) before and after the implementation of highly active antiretroviral therapy (HAART) in a teaching hospital (HUCFF/UFRJ), reference for acquired immunodeficiency syndrome (AIDS), in Rio de Janeiro,
F. C. Q. Mello, A. P. M. Lacerda, C. Gounder, F. B. Madeira, A. L. Kritski (Rio de Janeiro, Brazil; Baltimore, United States Of America)
| |
Adverse reactions to the tuberculosis treatment
C. M. Pop, C. D. Zamora, M. A. Goron (Cluj-Napoca, Romania)
| |
Synthetic peptide gamma-D-Glutaminyl-L-Tryptophan has antituberculosis activity in murine model
A. Simbirtsev, N. Zabolotnych, A. Kolobov, N. Pigareva, A. Kotov, E. Minaeva, T. Vinogradova (Saint-Petersburg, Russia)
| |
Comparison of serum anti-tuberculous glycolipid antigen antibodies among the patients of tuberculous and nontuberculous pulmonary diseases
A. Nakamura, Y. Yamada, M. Itoh, M. Kajiura, T. Matsuura, K. Yoshitomo (Nagoya, Aichi, , Ichinomiya, Japan)
| |
Mycobacterium tuberculosis (MTB) content in the air of in-patient facility for the management of pulmonary tuberculosis (TB)
O. V. Lovacheva, L. N. Tchernooussova, V. V. Goryunov, P. P. Seltsovsky, L. V. Slogotskaya, O. A. Irtuganova (Moscow, Russia)
| |
The assessment of the efficacy of a standard chemotherapy regimen in the treatment of new sputum-positive tuberculosis (TB) patients
V. Y. Mishin (Moscow, Russia)
| |
The tuberculosis situation in Ukraine during 1990-1999
V. M. Melnyk, A. V. Koblanskaya, V. G. Matusevych, N. A. Lapteva, T. S. Kucher (Kiev, Ukraine)
| |
Introduction of DOTS strategy in Kyrgyz Republic
A. S. Alisherov, G. D. Malaeva (Bishkek, Kyrgyzstan)
| |
Study on TB relapses compared with new cases in Cluj, Romania
M. V. Cirstoniu Mihaela (Cluj Napoca, Romania)
| |